Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Doximity (DOCS) EBITDA Margin (2020 - 2025)

Doximity has reported EBITDA Margin over the past 6 years, most recently at 38.85% for Q4 2025.

  • Quarterly EBITDA Margin fell 855.0% to 38.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 37.44% through Dec 2025, down 273.0% year-over-year, with the annual reading at 39.94% for FY2025, 547.0% up from the prior year.
  • EBITDA Margin was 38.85% for Q4 2025 at Doximity, up from 37.79% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 47.4% in Q4 2024 and troughed at 23.92% in Q2 2022.
  • The 5-year median for EBITDA Margin is 34.73% (2025), against an average of 34.61%.
  • Year-over-year, EBITDA Margin surged 2851bps in 2021 and then crashed -1031bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 36.57% in 2021, then dropped by -9bps to 33.39% in 2022, then rose by 30bps to 43.28% in 2023, then increased by 10bps to 47.4% in 2024, then decreased by -18bps to 38.85% in 2025.
  • Per Business Quant, the three most recent readings for DOCS's EBITDA Margin are 38.85% (Q4 2025), 37.79% (Q3 2025), and 37.36% (Q2 2025).